Dr. Fauci says Covid vaccines appear to be much less efficient in opposition to some new strains

New data shows that the Covid-19 vaccines currently on the market may not be as effective at protecting against new, more contagious strains of the coronavirus, said White House Health Advisor Dr. Anthony Fauci, on Thursday.

A handful of new strains of the coronavirus have emerged overseas, giving scientists cause for concern. Some variants identified in the UK, South Africa, and Brazil appear to be more transmissible than previous strains, but not necessarily more deadly.

While it’s no surprise that the virus is mutating, researchers are quick to figure out what the changes could mean for recently developed life-saving vaccines and therapeutics for the disease.

Some early results, published on the preprint server bioRxiv and not yet peer-reviewed, indicate that the variant identified in South Africa may evade the antibodies of some coronavirus treatments and reduce the effectiveness of the currently available range of vaccines.

Even if the drugs are less effective, they will likely still provide enough protection to make the vaccines worthwhile, Fauci said. Both Pfizer and Moderna vaccines have been shown to be highly effective, creating a “cushioning effect” that would allow some decrease in their effectiveness.

A decline in the effectiveness of vaccines would be “all the more a reason why we should vaccinate as many people as possible”. Mutations occur when the virus spreads and replicates. This can be suppressed if enough people are vaccinated against the disease to develop what is known as herd immunity.

“Bottom line: We are very careful. There are alternative plans if we ever need to modify the vaccine. It’s not a very burdensome thing, we can do it given the platforms we have,” Fauci said during the White House press conference .

This is a developing story. Please try again later.

Based on the CDC, the Biden administration is looking for out what’s delaying vaccination with Covid vaccines

Courtney Senechal, RN, prepares to administer the second Moderna vaccine for Covid-19 on January 19, 2021 at the East Boston Neighborhood Health Center in Boston.

Jonathan Wiggs | Boston Globe | Getty Images

The Biden government is trying to figure out exactly what is holding up the national rollout of Covid-19 vaccines and looking for hiccups in the manufacturing process, suppliers and distribution networks, said Dr. Rochelle Walensky, the new director of the Centers for Disease Control and Prevention.

President Joe Biden has vowed to give 100 million shots in his first 100 days in office, forcing the US to slightly speed up current vaccination rates. However, some large states are telling the federal government that they are able to vaccinate even more people but are not receiving enough doses.

Walensky said the government is looking at what could restrict the supply of cans and is ready to apply the Defense Production Act, a warfare measure that will force US companies to make supplies that are vital to national security to boost production.

“We are working closely with General Perna, the manufacturers and the states to understand exactly where the offer is,” Walensky said on Thursday on the “Today” show. General Gustave Perna was tasked with overseeing the logistics for President Donald Trump’s vaccination program, Operation Warp Speed.

“The president has a plan to apply the Defense Production Act to see exactly what resources we need, either for vaccine manufacture or vaccine distribution or vaccine delivery. Do we need or do we need syringes?” do we need chemical products? “Walensky added.” We are working on answering these questions. We’ll be in the driver’s seat on the second day. “

In Biden’s Covid-19 Response Plan released Thursday, his government said it would instruct authorities to contact the Data Protection Authority if necessary to ensure supplies were in place for the pandemic response. This could include protective equipment such as masks as well as consumables needed for Covid-19 testing and for administering and manufacturing vaccines such as certain chemicals and syringes.

The Trump administration invoked the bill last year to get U.S. manufacturers to make ventilators and other consumables, but was reluctant to use the martial law to procure consumables for vaccine makers like Pfizer.

Even as the administration scrutinizes the supply chain to see if it can promote the production, distribution, and management of recordings, Walensky still believes that some recordings are going unused. Nearly 36 million doses had been given to states as of Wednesday, according to the CDC, but only about 16.5 million had actually been given.

Walensky said the government intends to open more vaccination centers in stadiums and gyms, as well as mobile vaccination units, to get those doses in their arms. She said the government is working with states to adjust licensing requirements for the vaccine to match demand with supply.

The government is trying to get more people like dentists and veterinarians to give the vaccine, she said.

However, many of the doses that appear not to have been used are only due to delays in local data reporting and do not reflect reality, said Dr. Marcus Plescia, Chief Medical Officer of the Association of State and Territorial Health Officials.

He said some cans may not have been used because they are specifically for federal programs like partnering with retail pharmacies like CVS and Walgreens that are not yet fully operational. But, he said, most states, counties, and hospitals are quick to manage the admissions they get and actually need more care from the federal government.

When asked about the long-term vaccination schedule, Walensky said the government was sticking to its goal of 100 million doses in the first 100 days, but acknowledged that “after 100 days, many Americans still need vaccines”.

She noted that the Food and Drug Administration is expected to receive data from Johnson & Johnson soon on the safety and effectiveness of their Covid-19 vaccine. Public health officials have high hopes for this vaccine as it is a one-shot program that simplifies the process of dissemination for the public. The shot has been shown to be safe in early clinical trials and appears to produce a promising antibody response, but data from the Phase 3 study has not yet been published.

Biden’s inaugural tackle attracts tens of millions extra viewers than Trump’s

Biden’s inaugural address was seen by nearly 2 million more television viewers than it was hired for Donald Trump in 2017.

New York Times media reporter John Koblin tweeted the numbers:

Joe Biden’s inaugural address attracted a larger television audience than Trump’s 2017 speech

Yesterday: 39.8 million viewers
2017: 38.3 million viewers

CNN had the most viewers (10 million), Fox News last (2.7 million)

– John Koblin (@koblin) January 21, 2021

First, Biden beat Trump by millions of votes on election day, and then he beat Trump by millions of viewers on inauguration day.

Biden’s ability to get better viewership than Trump should once and for all destroy the myth that Trump himself created of being a must-see on TV and a rating. President Biden delivered a speech that was highly praised by everyone outside Trump’s greatest propagandists.

Joe Biden understands the concept that less is more. The American people don’t want a president who demands their attention 24 hours a day, seven days a week. Biden made his inaugural address at about twenty minutes, stepped off the stage, and after a few ceremonial stops, went to work for the American people.

Biden is the president that the majority of Americans elected and they are prepared to be reminded of what a normal president looks and acts like.

For more discussions on this story, join our Rachel Maddow and MSNBC groups.

Follow and like PoliticusUSA on Facebook

Mr. Easley is the Founder / Executive Editor, White House Press Pool, and a Congressional Correspondent for PoliticusUSA. Jason has a bachelor’s degree in political science. His thesis focused on public order with a specialization in social reform movements.

Awards and professional memberships

Member of the Society of Professional Journalists and the American Political Science Association

Was wir seit dem ersten US-Fall gelernt haben, wurde bestätigt

Schwester Dawn Duran verabreicht Jeremy Coran während des Ausbruchs der Coronavirus-Krankheit (COVID-19) am 12. Januar 2021 in Pasadena, Kalifornien, USA, eine Dosis des COVID-19-Impfstoffs von Moderna.

Mario Anzuoni | Reuters

Heute vor genau einem Jahr bestätigten die Zentren für die Kontrolle und Prävention von Krankheiten den ersten Fall eines neuen Coronavirus auf US-amerikanischem Boden, den Wissenschaftler damals 2019-nCoV anriefen.

Seitdem hat das Land nach Angaben der Johns Hopkins University mehr als 24 Millionen Fälle und mehr als 400.000 Todesfälle verzeichnet. Ein neuer Präsident tritt sein Amt an und warnt davor, dass sich die Pandemie verschlimmern wird, bevor sie sich bessert.

Experten für öffentliche Gesundheit, Ärzte, Wissenschaftler und Führungskräfte aus Industrie und Regierung sagen jedoch, dass uns das vergangene Jahr viel über das Virus beigebracht hat – und wie diese Lehren angewendet werden können, um die Pandemie jetzt zu verlangsamen.

Ihre Erkenntnisse reichten von Erkenntnissen über das Virus selbst und dessen Ausbreitung – erinnern Sie sich, als wir alle unsere Lebensmittel mit Clorox abwischten? – Überlegungen zu unserem eigenen Verhalten und wie es uns zu immer höheren Infektionsraten verurteilt.

Einige, von dem ehemaligen Mitglied des Nationalen Sicherheitsrates, Dr. Luciana Borio, und dem Chef der Operation Warp Speed, Moncef Slaoui, betonen, wie wichtig es ist, frühzeitig mit der Industrie zusammenzuarbeiten. Andere sagen, das vergangene Jahr beweise, dass das Versprechen unserer biomedizinischen Technologien schnell verwirklicht werden kann – wenn sie nur gut genug finanziert sind.

Hier sind ihre Gedanken.

Auf den Virus

“Es ist nicht das Winter-Atemwegsvirus, für das es in Rechnung gestellt wurde”, sagte Dr. Paul Offit vom Kinderkrankenhaus in Philadelphia. “Es ist weitaus weitreichender und schädlicher als das.”

Vorhersagen im Frühjahr über den Verlauf des Virus warnten davor, dass es den Mustern der Influenzapandemie von 1918 ähneln könnte: eine mildere erste Welle, gefolgt von einer viel tödlicheren zweiten im Herbst.

Der Herbst 2020 brachte letztendlich eine befürchtete größere Welle von Coronavirus-Fällen mit sich, aber es war nicht wie ursprünglich erwartet nach einem einheitlichen Tiefpunkt durch den Sommer. Mitte Juli erreichte ein Höhepunkt mit etwa 76.000 Fällen, als das Virus über Florida, Texas und Arizona verbreitet wurde.

Zu diesem Zeitpunkt hatten Wissenschaftler bereits einen Überblick darüber, was dieses Virus so schädlich macht, sagten Experten, da sich die Erkenntnisse in den ersten Monaten rasant entwickelten.

“Anfang Januar letzten Jahres wurde uns mitgeteilt, dass es keine Übertragung von Mensch zu Mensch gibt”, sagte Dr. Megan Ranney von der Brown University. “Als wir merkten, dass es sich ausbreitete [person-to-person]Wir dachten, es würde sich wie eine Grippe ausbreiten … wir dachten, wir müssten uns Sorgen um Tröpfchen und Fomiten machen. “

Das hat sich geändert, sagte Ranney, “als wir diese erste schreckliche nordöstliche Welle überstanden haben.”

Die Tatsache, dass die Übertragung “mehr in der Luft ist als ursprünglich angenommen, weniger oberflächlich als ursprünglich angenommen”, hat wichtige “Auswirkungen auf Präventionsempfehlungen”, sagte Dr. Carlos del Rio von der Emory University. Daher: Masken und Vermeidung großer Versammlungen in Innenräumen.

Wissenschaftler haben aber auch gelernt, dass dieses Virus schwieriger ist als andere. Die Tatsache, dass es einige tödlich trifft, während andere stillschweigend infiziert werden, macht es tatsächlich so gefährlich, sagte Dr. Jeremy Faust vom Brigham and Women’s Hospital in Boston.

“Asymptomatische Übertragung hat einerseits gute Nachrichten: Nicht jeder wird so krank, wie wir dachten”, sagte Faust. “Andererseits ist es so viel schwieriger zu kontrollieren, weil die Leute denken: ‘Wenn es mir gut geht, geht es mir gut. Ich darf keine Gefahr für mich selbst oder andere sein.'”

Dr. Leana Wen, ehemalige Gesundheitskommissarin von Baltimore, sagte, dass die Denkweise den größten Teil der Verbreitung ausmacht, wenn wir durchschnittlich fast 200.000 Fälle pro Tag aufzeichnen.

“Es gibt immer noch ein gewisses Maß an magischem Denken, wenn es um Menschen geht, die wir kennen und lieben und die nicht in unserem Haushalt sind”, sagte sie. “Wir denken, ‘Nun, diese Person sieht gut aus; ich kenne sie, ich vertraue ihnen, dass sie sich nicht auf risikoreiche Verhaltensweisen einlassen würden, also werde ich sie sehen.'”

Da Menschen ohne Symptome so viel Ausbreitung verursachen können – laut CDC mehr als die Hälfte -, ist es am besten, “jeden so zu betrachten, als ob er ein Coronavirus haben könnte”, sagte Wen.

Über menschliches Verhalten

“Wir haben das Gefühl einer sich verändernden Grundlinie entwickelt”, sagte Dr. Michael Osterholm von der University of Minnesota. Im April, sagte er, fühlte es sich an, als ob das “Haus in Flammen stand”, wobei jeden Tag 32.000 Fälle gemeldet wurden. Bis Mai waren es nur noch etwa 20.000. “Die Leute hatten das Gefühl, wir hätten die Kurve abgeflacht, wir waren fertig”, sagte er.

Bis Mitte Juli erreichte dieser Anstieg durch den Sonnengürtel einen bisher unergründlichen neuen Höchststand von mehr als 70.000 Fällen pro Tag. Anfang September fielen die Fälle auf 26.000 zurück, eine Zahl, die “fast so hoch war wie das Hoch im April, aber die Leute meinten:” Sehen Sie, das ist gut, es ist unter Kontrolle “, sagte Osterholm.

Im Oktober begann der obere Mittlere Westen mit einer Infektion zu leuchten, und “zu Thanksgiving hatten wir fast 200.000 Fälle pro Tag”, sagte er. Auf dem jüngsten Höhepunkt des Landes, dem 8. Januar, wurden an einem einzigen Tag mehr als 300.000 Fälle gemeldet.

“Denken Sie an 300.000 gegenüber 32.000”, sagte Osterholm. “In einem Zeitraum von April bis Januar wurden wir taub dafür. Jeder von ihnen ist eine sich verändernde Grundlinie, und plötzlich scheint das, was geschah, nicht mehr so ​​schlimm zu sein.”

Es sei Teil der menschlichen Verfassung, auf diese Weise zu reagieren, um “ein Gefühl des Überlebens zu entwickeln”. Aber es ist eine zentrale Herausforderung, das Blatt in der Pandemie zu wenden.

Auch, so Osterholm und Ranney, befassen sich mit den strukturellen Problemen, die die Hauptlast der Pandemie auf die Armen, Verletzlichen und Farbigen ausüben.

“Wenn wir Strategien für die öffentliche Gesundheit entwickeln oder umsetzen, um eine Epidemie zu bekämpfen, sei es struktureller Rassismus, wirtschaftliche Ungleichheit, Trennung zwischen Ländern mit hohem und niedrigem Einkommen, wenn wir nicht auf die Treiber des Verhaltens der Menschen achten, werden wir scheitern.” Sagte Ranney. “Auch mit guter Wissenschaft.”

Borio, der zusammen mit Osterholm als Covid-19-Berater für den Biden-Übergang fungierte, bezeichnete die Bedeutung der Führung als das wichtigste Lernen aus dem vergangenen Jahr.

“Es muss oben beginnen”, sagte sie. “Eine geteilte Nation kann eine Pandemie nicht bekämpfen. Unsere Regierung, riesig und komplex, verfügt über enorme Fähigkeiten, organisiert sich aber nicht selbst.”

Aber halten Sie die Politik so weit wie möglich davon ab, fügte Slaoui hinzu, der letzte Woche als Chefberater der Operation Warp Speed ​​zurückgetreten war, der Trump-Administration, die sich bemühte, Impfstoffe und Medikamente für Covid-19 zu entwickeln.

“Wir dürfen Fragen der öffentlichen Gesundheit nie wieder politisieren”, sagte Slaoui. “Ich bin sicher, das hat Zehntausende Menschenleben gekostet.”

Über Regierung und Industrie

Sowohl Slaoui als auch Borio sowie der frühere FDA-Kommissar Dr. Scott Gottlieb, der auch CNBC-Mitarbeiter und Vorstandsmitglied von Pfizer und Illumina ist, sagten, das erste Jahr der Pandemie habe gezeigt, wie wichtig öffentlich-private Partnerschaften sind und wie man auf sie einwirkt schnell.

“Die Weigerung von CDC, frühzeitig zu kommerziellen Labors und kommerziellen Testkits zu wechseln, hat uns für die frühe Verbreitung blind gemacht”, sagte Gottlieb.

Die Fähigkeit der USA, das Virus zu erkennen, wurde in den ersten Wochen durch einen Test der CDC beeinträchtigt, der sich als fehlerhaft herausstellte.

“Das Virus konnte tief in unseren Gemeinden verwurzelt werden”, fügte er hinzu. “Es war ein historischer Misserfolg.”

Borio wies auf die Bedeutung von Datensystemen hin, die von Palantir erstellt wurden, Gensequenzierungspartnerschaften mit Unternehmen wie Illumina, diagnostische Tests durch Quest und LabCorp sowie die Verteilung von Impfstoffen über CVS und Walgreens.

“Ein wirklich modernes öffentliches Gesundheitssystem erfordert eine öffentlich-private Partnerschaft”, sagte sie.

Borio betonte jedoch auch die Bedeutung der Strenge im Regulierungsprozess und die Gefahren einer “vorzeitigen Erteilung” der Genehmigung für den Notfall, “bevor Daten aus angemessenen und gut kontrollierten Studien vorliegen, wie sie für viele der Therapeutika aufgetreten sind”.

Insbesondere Hydroxychloroquin war ein blaues Auge für die Food and Drug Administration, die im Juni ihre Genehmigung zur Verwendung in Notfällen für Covid-19 widerrief, nachdem festgestellt wurde, dass es wahrscheinlich nicht wirksam ist.

Das, sagte Borio, “hilft den Patienten nicht.”

Slaoui, der die wissenschaftliche Entwicklung bei einer der größten öffentlich-privaten Partnerschaften in der Krankengeschichte durch Operation Warp Speed ​​beaufsichtigte, betonte auch die Notwendigkeit, bessere klinische Studien durchführen zu können. Er sagte an einigen Stellen im letzten Jahr, dass in den USA mehr als 400 Studien durchgeführt wurden, die meisten ohne Placebo-Kontrolle, was als Goldstandard für das Testen neuer Therapien gilt. Viele nahmen auch nur eine Handvoll Patienten auf.

“Das ist äußerst ineffizient und mit hohen Opportunitätskosten verbunden”, sagte Slaoui.

Auf Technologie

Was gut kontrollierte Studien jedoch bewiesen haben, war, dass “mRNA-Impfstoffe funktionieren”, sagte Ranney. “Die Tatsache, dass wir nicht nur einen, sondern zwei mRNA-Impfstoffe haben, die effektiv beim Menschen eingesetzt wurden und sowohl sicher als auch wirksam bei der Vorbeugung der Krankheit sind, ist einfach riesig.”

Laut Borio wären sie jedoch nicht möglich gewesen, “ohne frühzeitige Investitionen der US-Regierung vor vielen Jahren; die Entwicklung dieser Technologien dauert Jahre.”

Sie nannte sie die “aufregendste Innovation in der Impfstofftechnologie seit Jahrzehnten”.

Der Ausbruch bewies auch die Geschwindigkeit und Nützlichkeit einer zweiten Technologie, Impfstoffe, die harmlose Viren verwenden, um genetisches Material vom Coronavirus zu den Körperzellen zu befördern, um eine Immunantwort auszulösen, sagte Slaoui. “Es gibt mindestens zwei sehr schnelle Impfstoffplattformen, mit denen Impfstoffe in Monaten entwickelt werden können”, fügte er hinzu.

“Was wir vermisst haben”, sagte er, “sind Produktionskapazitäten und -fähigkeiten.”

Slaoui sagte, die Antwort sei etwas, das er als Biopräparationsorganisation bezeichnet habe, die neue Impfstoffe gegen neu auftretende Bedrohungen entwickeln und sofort Hilfe leisten könne, wenn diese Bedrohungen eintreten würden. Er brachte die Idee zum ersten Mal im Jahr 2016 auf, als er Vorsitzender der Impfstoffe bei GlaxoSmithKline war, und sagte, sie habe sich nicht durchgesetzt, “aber wir müssen sie jetzt wiederbeleben.”

Borio zitierte die Ernennung von Eric Lander zum besten Wissenschaftsberater von Biden in einer neu erhöhten Position auf Kabinettsebene als Signal für eine neue Ära, in der die Wissenschaft “ein wesentlicher Bestandteil des politischen Entscheidungsprozesses sein wird”.

Offit, ein Experte für Impfwissenschaft, drückte es ganz klar aus: “Wir haben es in uns, einen Impfstoff sehr schnell herzustellen und zu testen”, sagte er, “wenn wir bereit sind, das Geld auszugeben.”

Vorausschauen

Trotz der Lehren aus dem ersten Jahr der Covid-19-Pandemie warnten Experten des öffentlichen Gesundheitswesens vor einem schwierigen Weg nach vorne.

“Was mir am meisten auffällt, ist, wie viel wir noch nicht wissen”, sagte Dr. Kayvon Modjarrad, Direktor der Abteilung für neu auftretende Infektionskrankheiten am Walter Reed Army Institute of Research.

Fragen wie: Wie verhält sich dieses Virus anders als andere Atemwegsviren? Wie entwickelt es sich? Warum verursacht es bei einigen so schwere Krankheiten, bei anderen jedoch asymptomatisch?

“In der Wissenschaft besteht der erste große Schritt zur Lösung eines der Rätsel der Natur darin, zu verstehen, wie groß das Rätsel ist und welche Fragen zu stellen sind”, sagte Modjarrad. “Wir erreichen diesen Punkt erst jetzt.”

Eine der dringendsten Herausforderungen besteht darin, dass eine als B.1.1.7 bekannte Variante, die als übertragbarer angesehen wird als frühere Formen des Coronavirus, wahrscheinlich “in den nächsten Wochen bis Monaten abheben wird”, sagte Osterholm. Das heißt: “Wir konnten die schlimmsten Tage der Pandemie vor uns sehen, selbst mit dem Impfstoff.”

Zu den dringendsten Aufgaben der Biden-Regierung gehört die Verwaltung der Verteilung von Coronavirus-Impfstoffen, für die ein Ziel von 100 Millionen Dosen festgelegt wurde, die in den ersten 100 Tagen verabreicht wurden.

Osterholm stellte jedoch fest, dass in diesem Tempo – selbst wenn ein zusätzlicher Impfstoff für die Verwendung freigegeben wird, für den nur eine Dosis erforderlich ist, wie Johnson & Johnson’s in den nächsten Monaten erwartet wird – nur etwa 14% der US-Bevölkerung vollständig von geimpft würden Ende April.

Zusammen mit geschätzten 30% der Bevölkerung, die bereits infiziert sind und möglicherweise Immunität haben, ist dies weniger als die Hälfte des Landes, das bis in den Mai hinein geschützt ist, “weit entfernt von jeglicher Herdenimmunität”, sagte Osterholm.

“Impfstoffe spielen keine Rolle, nur Impfungen”, fügte Modjarrad hinzu, Direktor der Abteilung für neu auftretende Infektionskrankheiten am Walter Reed Army Institute of Research. “Wir können uns nicht zu viel gratulieren oder zu früh den Sieg erklären.”

Dr. Anthony Fauci, der landesweit führende Wissenschaftler für Infektionskrankheiten, sagte diese Woche, er erwarte, dass das Land 75 bis 80% seiner durch den Herbst geimpften Bevölkerung erreichen könne.

“Wenn wir das von April, Mai, Juni, Juli, August an effizient tun”, sagte er den Gastgebern eines Livestreams von Harvard Business Review, “sollten wir bis zum Beginn des Herbstes das Maß an Schutz haben, das wir haben.” Ich denke, wir können zu einer Form der Normalität zurückkehren. “

TSR Unique: Michelle Obama’s Hairdresser Yene Damtew Let Us Know All About Her Inauguration Day Hair That The Present Stole!

Roommates, social media are still choking Michelle Obama’s inauguration day look – and while her fashion was definitely top notch, it was her bouncy, flowing hair that made her jaw drop. We met Michelle’s personal hairdresser Yene Damtew and got a glimpse of how she killed and laid Michelle’s hair for the big day!

When we asked Yene Damtew if there was a plan in mind or if she freestyled Michelle Obama’s hair on inauguration day, she stated:

“I hadn’t thought about it days before. But when I saw the clothes and coat that Meredith Koop had picked out, I knew the hairstyle had to complete the entire look. I also look at the forecast and assume how long it will be out in the elements. I wanted to create a sleek look that would turn heads, but I also wanted a style that would last for hours without me by her side for a quick touch-up. The larger curls are easier to manage and hold up very well. She didn’t give me a specific direction. We have been working together for more than a decade which is a blessing. At this point we know each other. She trusts me to pick a style that works and I trust she will allow me to be creative. I knew Ms. Obama would wear a monochrome look, so I knew the hair had to stand out by itself. “

She went on and also gave us the tea about how long it took for her hair to style Michelle’s hair:

“Not too long, I’ve been doing this for a while. But Carl and I combined hair and makeup at the same time. So we had to work with and around each other and at the same time watch the clock so that we weren’t late. The inauguration is a well-timed event, so there was no delay for this day. “

Now you know we have you, so we also asked Yene what products she used on our Forever First Lady’s hair – so we can all shop quickly. She told us, “I have a number of products and tools that I use depending on the look I create. My kit always has a good feather comb, a rattail comb, a solid press comb, a gold Marcel iron and a flexible hairspray like Oribe superfine. For this look, I used Amika Headstrong hairspray for the finish and the Mizani 25miracle had given off moisture beforehand. “

Yene also gave a little backstory on how she got the great opportunity to work with Michelle Obama as her personal hairdresser over 10 years ago. “I’ve had a relationship with Obama since 2009. I worked for their then stylist who is my mentor and he took me to the White House where I was helping the entire family with hair needs. Working in the White House for eight years was one of the highest honors of my life. My relationship with Ms. Obama has remained strong in her post-First Lady life. I was blessed to stay on their style team along with my friends Carl Ray (makeup) and Meredith Koop (clothing). I did hair for her bestselling book “Becoming” and accompanied her on her two-year book tour around the world. I see her not only as a client, but also as a friend and mentor, ”she said.

We love to see that double dose of #BlackGirlMagic!

Would you like tea right in your inbox? Visit us at 917-722-8057 or click here to join!

Russia’s Sputnik vaccine receives its first approval within the EU, United Arab Emirates

A medical worker fills a syringe with the Gam-COVID-Vac vaccine (under the brand name Sputnik V) in Butovo, in southern Moscow.

Sergei Savostyanov | TASS | Getty Images

DUBAI, United Arab Emirates – Russian vaccine Sputnik V Covid-19 saw a number of improvements on Thursday as Hungary and the United Arab Emirates became the first countries in the European Union and the Gulf region to register the emergency shot.

Hungary’s decision was confirmed by President Viktor Orban’s spokesman, who said that if the country agrees to a shipping agreement with Moscow, it will be the first country in the European Union to receive the vaccine. This is because the country’s cases have fallen from a high of more than 6,000 a day in early December to below 2,000 a day.

“This decision is very important as it shows that over 90% of the vaccine’s safety and efficacy is valued by our partners in Hungary,” said Kirill Dmitriev, head of the Russian Direct Investment Fund, in a statement.

The EU drug regulator has not yet approved the Russian stab, although Chancellor Angela Merkel gave Sputnik further hope on Thursday, suggesting that the German vaccine regulator could advise Russia on steering the EU approval process. The RDIF has submitted Sputnik for EU registration and expects its review in February.

UAE approval comes amid a dramatic surge in infections

The UAE approval comes amid a record spike in cases in the little Gulf Sheikh, which excelled internationally by welcoming tourists and fully reopening its economy by late summer last year.

Confirmed coronavirus cases have more than tripled in about three weeks, prompting Emirati authorities to suspend unnecessary hospital surgery and “entertainment” activities in their busy hotels and restaurants just days after the country gave assurances that the virus was under Control was to fail.

The UAE’s daily number of cases hit a record high of 3,529 on Thursday, well above neighboring Gulf states, where registered infections are below 500 per day.

A man from the Emirates wearing a protective mask walks at al-Barsha Health Center in the Gulf of Dubai on December 24, 2020.

GIUSEPPE CACACE | AFP via Getty Images

Sputnik V will be the third vaccine to be used in the United Arab Emirates after China’s Sinopharm vaccine and the Pfizer BioNTech vaccine developed in the US and Germany were released to the public in December. The country of around 10 million people is running the second fastest national vaccination campaign in the world after Israel per capita, according to the government, and aims to vaccinate half of the country’s population by the end of March.

“The decision is part of the UAE’s comprehensive and integrated efforts to ensure a higher level of prevention,” the country’s health ministry said in a statement on Thursday about Sputnik’s approval. “The study results have demonstrated the vaccine’s effectiveness in eliciting a strong antibody response to the virus, its safety to use and its compliance with international safety and efficacy standards.”

Lack of late-stage experimental data

The approvals were granted despite the fact that no data on the results of the phase 3 human study of the vaccine have been published. The capital of the United Arab Emirates, Abu Dhabi, began phase 3 testing for Sputnik V earlier this month but has not released any data on it. 1,000 volunteers in the emirate have received their first dose, according to RDIF.

Sputnik V, which according to its developer, the Gamaleya Research Institute, is 91% effective after two doses, has been used across Russia for months. Scientists expressed concern about what many have described as the rush to launch the vaccine, which gave the green light for mass use in Russia ahead of the completion of Phase 3 trials.

As the first step in the largest vaccination campaign in Argentina’s history, first line health workers are receiving the Russian Sputnik V vaccine against the coronavirus.

Patricio Murphy | SOPA pictures | LightRocket | Getty Images

Analysis of the phase 1 and phase 2 studies of the vaccine was published in The Lancet in September, which found that the initial results did not show any significant negative side effects, but further studies were required.

“The results of the Phase III clinical trials are expected to be published shortly,” according to the official Sputnik V.

Prior to Thursday’s announcements, it had been approved for emergencies in 9 countries and territories outside of Russia – Algeria, Argentina, Bolivia, Belarus, Serbia, Venezuela, Paraguay, Turkmenistan and the Palestinian Territories.

In England’s third lockdown, there aren’t any indicators of decline in some instances

Medics transfer a patient from an ambulance to the Royal London Hospital in London on January 19, 2021.

TOLGA AKMEN | AFP | Getty Images

LONDON – A third national lockdown in England appears to have had little impact on the rising rate of coronavirus infection, according to the results of a large study, with the prevalence of the virus showing “no signs of decline” in the first 10 days of the year, on a more severe basis Restrictions.

The closely watched REACT-1 study, led by Imperial College London, warned that if the prevalence of the virus in the community were not significantly reduced, the health system would remain under “extreme pressure” and the cumulative death toll would rise rapidly.

The results of the preprint report, released Thursday by Imperial College London and Ipsos MORI, come shortly after the UK recorded another all-time high in coronavirus deaths.

Government figures released on Wednesday showed an additional 1,820 people had died within 28 days of a positive Covid test. To date, the UK has registered 3.5 million coronavirus cases with 93,290 deaths.

UK Prime Minister Boris Johnson speaks during a press conference on Coronavirus (COVID-19) on Downing Street on January 15, 2021 in London, England.

Dominic Lipinski | Getty Images

Prime Minister Boris Johnson said the latest numbers were “appalling” and warned: “There are still difficult weeks ahead.”

Johnson imposed lockdown measures in England on January 5, ordering people to “stay home” as most schools, bars and restaurants had to close. The strict public health measures are expected to remain in place until at least mid-February.

What were the main results?

The REACT-1 study tests nasal and throat swabs roughly monthly from 120,000 to 180,000 people in the UK community. The most recent results mainly cover a period January 6-15.

The study compared the results of swabs collected between November 13 and 24 and those collected between November 25 and December 3.

The researchers found 1,962 positives from 142,909 swabs removed in January. This means that 1.58% of the people tested had Covid on a weighted average.

This corresponds to an increase in prevalence rates of more than 50% since the results of the study in mid-December and is the highest value REACT-1 has recorded since it began in May 2020.

The prevalence from January 6-15 was highest in London. According to one study, 1 in 36 people infected was more than twice as likely as the previous REACT-1 results.

A man wearing a mask as a preventive measure against the spread of Covid-19 goes for a walk in London.

May James | SOPA pictures | LightRocket via Getty Images

In the south-east of England, the east of England and the West Midlands, the infections had more than doubled compared to the results published in early December.

“Our data shows worrying evidence of a recent surge in infections that we will continue to monitor closely,” said Professor Paul Elliott, program director at Imperial, in a statement.

“We are all helping to keep this situation from getting worse and we must do our best to stay home wherever possible,” he added.

The UK Department of Health and Welfare said the full effects of the lockdown measures were not yet reflected in the prevalence figures reported in the REACT-1 study.

“These results show why we cannot be on our guard in the coming weeks,” said Health Secretary Matt Hancock.

“It’s absolutely essential that everyone does their part to help alleviate infection. This means staying at home and only going out where absolutely necessary, reducing contact with others and maintaining social distance,” said Hancock.

5 issues it’s best to know earlier than the inventory market opens on January 21, 2021

Here are the top news, trends, and analysis investors need to get their trading day started:

1. Dow wants to contribute to the record closing on Wednesday

Traders watch the President’s inauguration on the New York Stock Exchange.

NYSE

US stock futures rose Thursday after the Dow Jones Industrial Average, S&P 500, and Nasdaq all closed at record highs with President Joe Biden taking office. Biden got to work and signed a number of executive orders, including one requiring Covid masks on federal properties. He is expected to sign 10 pandemic commands on Thursday on his first full day as president. Wall Street has bet on yet another coronavirus stimulus package and a smoother introduction of vaccines under Biden this year. So far, the Dow is up nearly 2% in 2021; the S&P 500 is up more than 2.5%; and the Nasdaq is up 4.4%.

Bitcoin slumped for a second day on Thursday, increasing digital currency losses to more than 10% in 48 hours and wiping billions of dollars from the crypto market. Bitcoin has had some wild weeks of volatility, briefly hitting a record high of over $ 41,940 earlier this month before falling sharply.

2. Unemployment claims fall, but remain elevated

As part of a campaign by Goldman Sachs to support small businesses near the U.S. Capitol in Washington, DC on January 5, 2021, signs are being erected calling for more relief, a second paycheck protection program, and assistance to elected officials.

BRENDAN SMIALOWSKI | AFP | Getty Images

The Department of Labor reported fewer than expected 900,000 new claims for unemployment benefit for the week ended January 16 on Thursday morning. The previous week’s total number of unemployment claims was reduced by 39,000 to 926,000. However, these numbers are still among the highest since late August.

3. The quarterly results continue to flow in

Dow Stock Travelers tops the list of companies reporting profits Thursday morning. The insurance giant reported earnings per share of $ 4.91 for the fourth quarter, well above expectations. Net written premiums increased 3% to $ 7.27 billion. Stocks rose 2%. Dow components Intel and IBM released quarterly results after the closing bell. Both stocks were higher in the pre-market.

United Airlines loads vaccines onto the plane

United

However, United Airlines shares fell 2% on the Thursday before trading, a day after the airline warned that sales would suffer earlier this year as the pandemic continues. United posted a higher than expected loss of $ 7 per share in the fourth quarter. Sales of $ 3.41 billion also fell short of estimates. The company expects it will exceed its pre-pandemic margins by 2023.

4. Biden describes 10 instructions from the executive to fight Covid

President Joe Biden signs Executive Orders in the Oval Office of the White House in Washington upon his inauguration as the 46th President of the United States on January 20, 2021.

Tom Brenner | Reuters

Biden released the details of his comprehensive plan to fight the coronavirus early Thursday. He announced 10 executive orders and directed the authorities to use US powers during the war to manufacture N95 masks, swabs and other equipment to fight the pandemic. The biden approach to Covid takes place one year after the day of the first reported coronavirus case in the United States. Since then, there have been more than 24.4 million infections and at least 406,147 deaths. In fact, Wednesday’s death toll was the second highest in the pandemic at over 4,370.

5. The newly democratically controlled Senate gets to work

Democratic Senate nominees Jon Ossoff (L), Raphael Warnock (C) and U.S. President-elect Joe Biden (R) take to the stage during a rally outside Center Parc Stadium in Atlanta, Georgia on Jan. 4, 2021.

Jim Watson | AFP | Getty Images

The Senate Finance Committee is expected to vote on Friday on the appointment of former Fed chief Janet Yellen as von Biden’s Treasury Secretary. On Wednesday evening, the Senate confirmed Avril Haines as director of the national intelligence service, making her the first official member of Biden’s cabinet.

With the swearing-in of Georgia’s two new Democratic Senators on Wednesday, their party took control of the Senate in a 50:50 split, with Vice President Kamala Harris casting the casting vote. The Senate needs to balance consideration of Biden’s political agenda and the impeachment process of former President Donald Trump. The Senate proceedings cannot begin until Parliament presents the only impeachment notice against Trump for inciting the uprising on January 6 in the US Capitol.

– Follow all developments on Wall Street in real time with CNBC Pro’s live market blog. Find out about the latest pandemics on our coronavirus blog.

Working mates for all times: Kamala Harris & Doug Emhoff’s love story

“As a single professional woman in my forties and in public, dating has not been easy,” she wrote in her book. “I knew that if I took a man to an event, people would immediately start speculating about our relationship. I also knew that single women are viewed differently in politics than single men. We don’t have the same leeway, when it comes to.” I was not interested in inviting this type of exam unless I was almost certain that I had found ‘The One’ – which meant that I kept my personal life separate from my career for years. “

By one day in 2013, she decided to face this particular trial, and invited Doug, a trial colleague she had been with for six months, to an event where she was supposed to talk about dropping out of elementary school. Your best friend Chrisette Hudlin, a mutual connection, felt that the Brooklyn-born, New Jersey-born California transplant seemed like someone Kamala would like to have. So, similar to the love story of the Hollywood character Meghan Markle and revered royal Prince Harrythe entertainment attorney and the attorney general were established.

But while the Duke and Duchess of Sussex’s first meeting place was on Dean Street by Soho House in London, Kamala and Doug hit it off by phone first – starting with an introductory text from him, followed by a voicemail the next day that he was sure of had finished things before they began.

“The voicemail I have saved to this day was long and a little confusing,” she described in her book. “He sounded like a nice guy though, and I was intrigued to learn more. Doug, however, was pretty sure he’d ruined his chances.”

Instead, it was the future vice presidential candidate who next initiated a call, and as the hour they were on the phone shows, the odds were very good.

The Senate approves Avril Haines, the primary member of the Biden cupboard

Avril Haines speaks during her confirmation hearing before the Senate Intelligence Committee that she will be President-elect Joe Biden’s National Intelligence Directorate on January 19, 2021 in Washington, DC.

Joe Raedle | Pool | Reuters

WASHINGTON – The Senate confirmed Avril Haines as director of national intelligence on Wednesday evening, making her the first official member of President Joe Biden’s cabinet.

Before the evening was adjourned, the Senate voted 84-10 on Haines’ confirmation.

Haines, Biden’s election to head the nation’s 18 intelligence agencies, is the first woman to hold the position.

“Our opponents will not stand by and wait for the new government to fill critical positions, and I am pleased that my Senate colleagues, together with me, have quickly confirmed Director Haines for this important post,” said Senator Marco Rubio, R-Fla., Vice chairman of the Senate Select Committee on Intelligence, wrote in a statement.

“Avril Haines was the right choice for the director of the National Intelligence Service,” wrote Senate Majority Leader Chuck Schumer, DN.Y., in a statement Wednesday evening. “We appreciate the bipartisan collaboration to be confirmed tonight and we hope there will be much more of it as the nation is in crisis and we need to deploy President Biden’s team as soon as possible,” he added.

White House press secretary Jen Psaki said in her first briefing Wednesday night that the gathering was of paramount importance to Biden’s cabinet and his national security team.

On Tuesday, Haines told the Senate Intelligence Committee, which had voted on her nomination, that one of her main initiatives would be to build trust in the country’s intelligence services.

“The DNI must never shrink from telling the truth to power – even if it can be impractical or difficult,” said Haines. “The DNI must insist that when it comes to intelligence, there is simply no place for politics – never.”

Susan Rice (left), Avril Haines and Lisa Monaco with President Barack Obama in December 2015.

Pete Souza | The White House | Wikipedia

Prior to joining the Biden administration, Haines was deputy national security adviser to former President Barack Obama.

Previously, she was also the CIA deputy director. She is the first woman to hold both positions.